HIGHLIGHTS
- who: Jian Zhu from the California State University, Los Angeles, United States have published the article: Case Report: Recombinant Human Endostatin Plus Chemotherapy for Epidermal Growth Factor Receptor-Negative Miliary Lung Adenocarcinoma, in the Journal: (JOURNAL)
- how: Due to the lack of a specific treatment strategy for EGFR-negative MIPC the authors used PD-1 inhibitor as a tentative solution.
SUMMARY
Miliary intrapulmonary carcinomatosis (MIPC) is a rare lung cancer presentation characterized by diffuse, tiny and discrete pulmonary micronodules. Typical metastatic miliary nodules of lung cancer is rarely seen in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.